{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AKT1", "drug discovery", "molecular dynamics simulation", "natural compounds", "oral squamous cell carcinoma", "personalized medicine", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35887580", "DateRevised": {"Year": "2022", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["1083", "10.3390/jpm12071083"], "Journal": {"ISSN": "2075-4426", "JournalIssue": {"Volume": "12", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "30"}}, "Title": "Journal of personalized medicine", "ISOAbbreviation": "J Pers Med"}, "ArticleTitle": "Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma.", "Abstract": {"AbstractText": ["Oral squamous cell carcinoma (OSCC) is a major cause of death in developing countries because of high tobacco consumption. RAC-alpha serine-threonine kinase (AKT1) is considered as an attractive drug target because its prolonged activation and overexpression are associated with cancer progression and metastasis. In addition, several AKT1 inhibitors are being developed to control OSCC and other associated forms of cancers. We performed a screening of the IMPPAT (Indian Medicinal Plants, Phytochemistry and Therapeutics) database to discover promising AKT1 inhibitors which pass through various important filters such as ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties, physicochemical properties, PAINS (pan-assay interference compounds) filters, PASS (prediction of activity spectra for substances) analysis, and specific interactions with AKT1. Molecules bearing admirable binding affinity and specificity towards AKT1 were selected for further analysis. Initially, we identified 30 natural compounds bearing appreciable affinity and specific interaction with AKT1. Finally, tuberosin and villosol were selected as potent and selective AKT1 inhibitors. To obtain deeper insights into binding mechanism and selectivity, we performed an all-atom molecular dynamics (MD) simulation and principal component analysis (PCA). We observed that both tuberosin and villosol strongly bind to AKT1, and their complexes were stable throughout the simulation trajectories. Our in-depth structure analysis suggested that tuberosin and villosol could be further exploited in the therapeutic targeting of OSCC and other cancers after further clinical validations."]}, "AuthorList": [{"Identifier": ["0000-0002-7080-6822"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, University of Hail, Hail P.O. Box 2440, Saudi Arabia."}], "LastName": "Adnan", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 26671, Bahrain."}], "LastName": "Jairajpuri", "ForeName": "Deeba Shamim", "Initials": "DS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Chaddha", "ForeName": "Muskan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Khan", "ForeName": "Mohd Shahnawaz", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Gachon University of Medicine and Science, Hambakmoeiro, Yeonsu-gu, Incheon 21924, Korea."}], "LastName": "Yadav", "ForeName": "Dharmendra Kumar", "Initials": "DK"}, {"Identifier": ["0000-0002-0399-4835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Mohammad", "ForeName": "Taj", "Initials": "T"}, {"Identifier": ["0000-0002-7003-9846"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Science, College of Applied Sciences-Qurayyat, Jouf University, Sakaka 72388, Saudi Arabia."}], "LastName": "Elasbali", "ForeName": "Abdelbaset Mohamed", "Initials": "AM"}, {"Identifier": ["0000-0002-1143-9233"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Health Sciences Research Unit, Jouf University, Sakaka 72388, Saudi Arabia."}], "LastName": "Abu Al-Soud", "ForeName": "Waleed", "Initials": "W"}, {"Identifier": ["0000-0002-0352-6900"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Science, College of Arts and Science, Najran University, Najran 66252, Saudi Arabia."}], "LastName": "Hussain Alharethi", "ForeName": "Salem", "Initials": "S"}, {"Identifier": ["0000-0002-3663-4940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "GrantList": [{"GrantID": "ISRM/12(22)/2020", "Agency": "Indian Council of Medical Research", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Pers Med", "NlmUniqueID": "101602269", "ISSNLinking": "2075-4426"}, "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Giat E., Ehrenfeld M., Shoenfeld Y. Cancer and autoimmune diseases. Autoimmun. Rev. 2017;16:1049\u20131057. doi: 10.1016/j.autrev.2017.07.022.", "ArticleIdList": ["10.1016/j.autrev.2017.07.022", "28778707"]}, {"Citation": "Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 2000;407:249\u2013257. doi: 10.1038/35025220.", "ArticleIdList": ["10.1038/35025220", "11001068"]}, {"Citation": "Lawen A. Apoptosis\u2014An introduction. Bioessays. 2003;25:888\u2013896. doi: 10.1002/bies.10329.", "ArticleIdList": ["10.1002/bies.10329", "12938178"]}, {"Citation": "Alwhaibi A., Verma A., Adil M.S., Somanath P.R. The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis. Pharmacol. Res. 2019;145:104270. doi: 10.1016/j.phrs.2019.104270.", "ArticleIdList": ["10.1016/j.phrs.2019.104270", "PMC6659399", "31078742"]}, {"Citation": "Alwhaibi A., Verma A., Artham S., Adil M.S., Somanath P.R. Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis. Biochem. Pharmacol. 2019;168:1\u201313. doi: 10.1016/j.bcp.2019.06.010.", "ArticleIdList": ["10.1016/j.bcp.2019.06.010", "PMC6733630", "31202735"]}, {"Citation": "Mishra A.P., Salehi B., Sharifi-Rad M., Pezzani R., Kobarfard F., Sharifi-Rad J., Nigam M. Programmed cell death, from a cancer perspective: An overview. Mol. Diagn. Ther. 2018;22:281\u2013295. doi: 10.1007/s40291-018-0329-9.", "ArticleIdList": ["10.1007/s40291-018-0329-9", "29560608"]}, {"Citation": "Cozzone D., Fr\u00f6jd\u00f6 S., Disse E., Debard C., Laville M., Pirola L., Vidal H. Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Diabetologia. 2008;51:512\u2013521. doi: 10.1007/s00125-007-0913-8.", "ArticleIdList": ["10.1007/s00125-007-0913-8", "18204829"]}, {"Citation": "Somanath P.R., Razorenova O.V., Chen J., Byzova T.V. Akt1 in endothelial cell and angiogenesis. Cell Cycle. 2006;5:512\u2013518. doi: 10.4161/cc.5.5.2538.", "ArticleIdList": ["10.4161/cc.5.5.2538", "PMC1569947", "16552185"]}, {"Citation": "Tremblay F., Lavigne C., Jacques H., Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat\u2013fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (\u03b6/\u03bb) activities. Diabetes. 2001;50:1901\u20131910. doi: 10.2337/diabetes.50.8.1901.", "ArticleIdList": ["10.2337/diabetes.50.8.1901", "11473054"]}, {"Citation": "Nakashiro K.-I., Tanaka H., Goda H., Iwamoto K., Tokuzen N., Hara S., Onodera J., Fujimoto I., Hino S., Hamakawa H. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma. Int. J. Oncol. 2015;47:1273\u20131281. doi: 10.3892/ijo.2015.3134.", "ArticleIdList": ["10.3892/ijo.2015.3134", "26315674"]}, {"Citation": "Sharif Siam M.K., Sarker A., Sayeem M.M.S. In silico drug design and molecular docking studies targeting Akt1 (RAC-alpha serine/threonine-protein kinase) and Akt2 (RAC-beta serine/threonine-protein kinase) proteins and investigation of CYP (cytochrome P450) inhibitors against MAOB (monoamine oxidase B) for OSCC (oral squamous cell carcinoma) treatment. J. Biomol. Struct. Dyn. 2021;39:6467\u20136479.", "ArticleIdList": ["32746771"]}, {"Citation": "Wang Y.W., Lin K.T., Chen S.C., Gu D.L., Chen C.F., Tu P.H., Jou Y.S. Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma. Hepatology. 2013;58:239\u2013250. doi: 10.1002/hep.26352.", "ArticleIdList": ["10.1002/hep.26352", "23460382"]}, {"Citation": "Priolo C., Pyne S., Rose J., Regan E.R., Zadra G., Photopoulos C., Cacciatore S., Schultz D., Scaglia N., McDunn J. AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer. Cancer Res. 2014;74:7198\u20137204. doi: 10.1158/0008-5472.CAN-14-1490.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-1490", "PMC4267915", "25322691"]}, {"Citation": "Sun M., Wang G., Paciga J.E., Feldman R.I., Yuan Z.-Q., Ma X.-L., Shelley S.A., Jove R., Tsichlis P.N., Nicosia S.V. AKT1/PKB\u03b1 kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 2001;159:431\u2013437. doi: 10.1016/S0002-9440(10)61714-2.", "ArticleIdList": ["10.1016/S0002-9440(10)61714-2", "PMC1850562", "11485901"]}, {"Citation": "Paoli P., Giannoni E., Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim. Biophys. Acta-Mol. Cell Res. 2013;1833:3481\u20133498. doi: 10.1016/j.bbamcr.2013.06.026.", "ArticleIdList": ["10.1016/j.bbamcr.2013.06.026", "23830918"]}, {"Citation": "Alzahrani A.S. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. Semin. Cancer Biol. 2019;59:125\u2013132. doi: 10.1016/j.semcancer.2019.07.009.", "ArticleIdList": ["10.1016/j.semcancer.2019.07.009", "31323288"]}, {"Citation": "Oudit G.Y., Sun H., Kerfant B.-G., Crackower M.A., Penninger J.M., Backx P.H. The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J. Mol. Cell. Cardiol. 2004;37:449\u2013471. doi: 10.1016/j.yjmcc.2004.05.015.", "ArticleIdList": ["10.1016/j.yjmcc.2004.05.015", "15276015"]}, {"Citation": "Liu P., Cheng H., Roberts T.M., Zhao J.J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat. Rev. Drug Discov. 2009;8:627\u2013644. doi: 10.1038/nrd2926.", "ArticleIdList": ["10.1038/nrd2926", "PMC3142564", "19644473"]}, {"Citation": "Karar J., Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front. Mol. Neurosci. 2011;4:51. doi: 10.3389/fnmol.2011.00051.", "ArticleIdList": ["10.3389/fnmol.2011.00051", "PMC3228996", "22144946"]}, {"Citation": "Jiang B.H., Liu L.Z. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv. Cancer Res. 2009;102:19\u201365. doi: 10.1016/j.bbapap.2007.09.008.", "ArticleIdList": ["10.1016/j.bbapap.2007.09.008", "PMC2933405", "19595306"]}, {"Citation": "Mitsiades C.S., Mitsiades N., Koutsilieris M. The Akt pathway: Molecular targets for anti-cancer drug development. Curr. Cancer Drug Targets. 2004;4:235\u2013256. doi: 10.2174/1568009043333032.", "ArticleIdList": ["10.2174/1568009043333032", "15134532"]}, {"Citation": "Cheng J.Q., Lindsley C.W., Cheng G.Z., Yang H., Nicosia S.V. The Akt/PKB pathway: Molecular target for cancer drug discovery. Oncogene. 2005;24:7482\u20137492. doi: 10.1038/sj.onc.1209088.", "ArticleIdList": ["10.1038/sj.onc.1209088", "16288295"]}, {"Citation": "Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free. Radic. Biol. Med. 2010;49:1603\u20131616. doi: 10.1016/j.freeradbiomed.2010.09.006.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.09.006", "PMC2990475", "20840865"]}, {"Citation": "Yun H.R., Jo Y.H., Kim J., Shin Y., Kim S.S., Choi T.G. Roles of autophagy in oxidative stress. Int. J. Mol. Sci. 2020;21:3289. doi: 10.3390/ijms21093289.", "ArticleIdList": ["10.3390/ijms21093289", "PMC7246723", "32384691"]}, {"Citation": "Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat. Rev. Drug Discov. 2009;8:579\u2013591. doi: 10.1038/nrd2803.", "ArticleIdList": ["10.1038/nrd2803", "19478820"]}, {"Citation": "Dutt R., Garg V., Khatri N., Madan A.K. Phytochemicals in anticancer drug development. Anti-Cancer Agents Med. Chem. 2019;19:172\u2013183. doi: 10.2174/1871520618666181106115802.", "ArticleIdList": ["10.2174/1871520618666181106115802", "30398123"]}, {"Citation": "Anjum F., Mohammad T., Almalki A.A., Akhtar O., Abdullaev B., Hassan M.I. Phytoconstituents and Medicinal plants for anticancer drug discovery: Computational identification of potent inhibitors of PIM1 kinase. OMICS J. Integr. Biol. 2021;25:580\u2013590. doi: 10.1089/omi.2021.0107.", "ArticleIdList": ["10.1089/omi.2021.0107", "34448628"]}, {"Citation": "Ashraf M.A. Phytochemicals as potential anticancer drugs: Time to ponder nature\u2019s bounty. BioMed Res. Int. 2020;2020:8602879. doi: 10.1155/2020/8602879.", "ArticleIdList": ["10.1155/2020/8602879", "PMC7013350", "32076618"]}, {"Citation": "Joshi B.S., Kamat V.N. Tuberosin, a new pterocarpan from Pueraria tuberosa DC. J. Chem. Soc. Perkin Trans. 1973:907\u2013911. doi: 10.1039/p19730000907.", "ArticleIdList": ["10.1039/p19730000907", "4735586"]}, {"Citation": "Pandey N., Tripathi Y.B. Antioxidant activity of tuberosin isolated from Pueraria tuberose Linn. J. Inflamm. 2010;7:47. doi: 10.1186/1476-9255-7-47.", "ArticleIdList": ["10.1186/1476-9255-7-47", "PMC2944242", "20836891"]}, {"Citation": "Li Q., Dong D.-D., Huang Q.-P., Li J., Du Y.-Y., Li B., Li H.-Q., Huyan T. The anti-inflammatory effect of Sonchus oleraceus aqueous extract on lipopolysaccharide stimulated RAW 264.7 cells and mice. Pharm. Biol. 2017;55:799\u2013809. doi: 10.1080/13880209.2017.1280514.", "ArticleIdList": ["10.1080/13880209.2017.1280514", "PMC6130567", "28112016"]}, {"Citation": "Zhao Z., Leister W.H., Robinson R.G., Barnett S.F., Defeo-Jones D., Jones R.E., Hartman G.D., Huff J.R., Huber H.E., Duggan M.E. Discovery of 2, 3, 5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors. Bioorg. Med. Chem. Lett. 2005;15:905\u2013909. doi: 10.1016/j.bmcl.2004.12.062.", "ArticleIdList": ["10.1016/j.bmcl.2004.12.062", "15686884"]}, {"Citation": "Mohammad T., Khan F.I., Lobb K.A., Islam A., Ahmad F., Hassan M.I. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4) J. Biomol. Struct. Dyn. 2019;37:1813\u20131829. doi: 10.1080/07391102.2018.1468282.", "ArticleIdList": ["10.1080/07391102.2018.1468282", "29683402"]}, {"Citation": "Mohammad T., Siddiqui S., Shamsi A., Alajmi M.F., Hussain A., Islam A., Ahmad F., Hassan M. Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: Combined molecular docking and simulation studies. Molecules. 2020;25:823. doi: 10.3390/molecules25040823.", "ArticleIdList": ["10.3390/molecules25040823", "PMC7070812", "32070031"]}, {"Citation": "Ali S., Khan F.I., Mohammad T., Lan D., Hassan M., Wang Y. Identification and evaluation of inhibitors of lipase from Malassezia restricta using virtual high-throughput screening and molecular dynamics studies. Int. J. Mol. Sci. 2019;20:884. doi: 10.3390/ijms20040884.", "ArticleIdList": ["10.3390/ijms20040884", "PMC6412828", "30781686"]}, {"Citation": "Naqvi A.A., Mohammad T., Hasan G.M., Hassan M. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 2018;18:1755\u20131768. doi: 10.2174/1568026618666181025114157.", "ArticleIdList": ["10.2174/1568026618666181025114157", "30360721"]}, {"Citation": "Morris G.M., Huey R., Olson A.J. Using autodock for ligand-receptor docking. Curr. Protoc. Bioinform. 2008;24:8\u201314. doi: 10.1002/0471250953.bi0814s24.", "ArticleIdList": ["10.1002/0471250953.bi0814s24", "19085980"]}, {"Citation": "Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis. 1997;18:2714\u20132723. doi: 10.1002/elps.1150181505.", "ArticleIdList": ["10.1002/elps.1150181505", "9504803"]}, {"Citation": "Mohammad T., Mathur Y., Hassan M.I. InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening. Brief. Bioinform. 2021;22:279. doi: 10.1093/bib/bbaa279.", "ArticleIdList": ["10.1093/bib/bbaa279", "33105480"]}, {"Citation": "Discovery Studio. Accelrys; San Diego, CA, USA: 2008. Version 2.1."}, {"Citation": "Mohanraj K., Karthikeyan B.S., Vivek-Ananth R., Chand R.B., Aparna S., Mangalapandi P., Samal A. IMPPAT: A curated database of I ndian M edicinal P lants, P hytochemistry A nd T herapeutics. Sci. Rep. 2018;8:4329. doi: 10.1038/s41598-018-22631-z.", "ArticleIdList": ["10.1038/s41598-018-22631-z", "PMC5847565", "29531263"]}, {"Citation": "Lipinski C.A. Lead-and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 2004;1:337\u2013341. doi: 10.1016/j.ddtec.2004.11.007.", "ArticleIdList": ["10.1016/j.ddtec.2004.11.007", "24981612"]}, {"Citation": "Reichel A., Lienau P. New Approaches to Drug Discover. Springer; Cham, Switzerland: 2015. Pharmacokinetics in drug discovery: An exposure-centred approach to optimising and predicting drug efficacy and safety; pp. 235\u2013260.", "ArticleIdList": ["26330260"]}, {"Citation": "Yadav D.K., Kumar S., Choi E.-H., Chaudhary S., Kim M.-H. Computational modeling on aquaporin-3 as skin cancer target: A virtual screening study. Front. Chem. 2020;8:250. doi: 10.3389/fchem.2020.00250.", "ArticleIdList": ["10.3389/fchem.2020.00250", "PMC7175779", "32351935"]}, {"Citation": "Waseem R., Anwar S., Khan S., Shamsi A., Hassan M., Anjum F., Shafie A., Islam A., Yadav D.K. MAP/Microtubule affinity regulating kinase 4 inhibitory potential of irisin: A new therapeutic strategy to combat cancer and Alzheimer\u2019s disease. Int. J. Mol. Sci. 2021;22:10986. doi: 10.3390/ijms222010986.", "ArticleIdList": ["10.3390/ijms222010986", "PMC8537121", "34681645"]}, {"Citation": "Cheon J.H., Kim K.S., Yadav D.K., Kim M., Kim H.S., Yoon S. The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochem. Biophys. Res. Commun. 2017;490:1176\u20131182. doi: 10.1016/j.bbrc.2017.06.178.", "ArticleIdList": ["10.1016/j.bbrc.2017.06.178", "28669723"]}, {"Citation": "Yadav D.K. Recent advances on small molecule medicinal chemistry to treat human diseases-Part III. Curr. Top. Med. Chem. 2021;21:1517\u20131518. doi: 10.2174/156802662117211007111027.", "ArticleIdList": ["10.2174/156802662117211007111027", "34727848"]}, {"Citation": "Baell J.B. Feeling nature\u2019s PAINS: Natural products, natural product drugs, and pan assay interference compounds (PAINS) J. Nat. Prod. 2016;79:616\u2013628. doi: 10.1021/acs.jnatprod.5b00947.", "ArticleIdList": ["10.1021/acs.jnatprod.5b00947", "26900761"]}, {"Citation": "Pires D.E., Blundell T.L., Ascher D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Daina A., Michielin O., Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Tiwari M.K., Coghi P., Agrawal P., Shyamlal B.R.K., Yang L.J., Yadav L., Peng Y., Sharma R., Yadav D.K., Sahal D. Design, synthesis, structure-activity relationship and docking studies of novel functionalized arylvinyl-1, 2, 4-trioxanes as potent antiplasmodial as well as anticancer agents. ChemMedChem. 2020;15:1216\u20131228. doi: 10.1002/cmdc.202000045.", "ArticleIdList": ["10.1002/cmdc.202000045", "32392362"]}, {"Citation": "Kalani K., Yadav D.K., Alam S., Khan F., Kashyap M.P., Srivastava S.K., Pant A.B. In-silico studies and wet-lab validation of camptothecin derivatives for anti-cancer activity against liver (HepG2) and lung (A549) cancer cell lines. Curr. Top. Med. Chem. 2021;21:908\u2013919. doi: 10.2174/1568026621666210426124719.", "ArticleIdList": ["10.2174/1568026621666210426124719", "33902420"]}, {"Citation": "Teli M.K., Kumar S., Yadav D.K., Kim M.-h. In silico identification of hydantoin derivatives: A novel natural prolyl hydroxylase inhibitor. J. Biomol. Struct. Dyn. 2021;39:703\u2013717. doi: 10.1080/07391102.2020.1714480.", "ArticleIdList": ["10.1080/07391102.2020.1714480", "31914862"]}, {"Citation": "Shyamlal B.R.K., Yadav L., Tiwari M.K., Mathur M., Prikhodko J.I., Mashevskaya I.V., Yadav D.K., Chaudhary S. Synthesis, bioevaluation, structure-activity relationship and docking studies of natural product inspired (Z)-3-benzylideneisobenzofuran-1 (3H)-ones as highly potent antioxidants and antiplatelet agents. Sci. Rep. 2020;10:2307. doi: 10.1038/s41598-020-59218-6.", "ArticleIdList": ["10.1038/s41598-020-59218-6", "PMC7012914", "32047204"]}, {"Citation": "Teli M.K., Kumar S., Yadav D.K., Kim M.h. In silico identification of prolyl hydroxylase inhibitor by per-residue energy decomposition-based pharmacophore approach. J. Cell. Biochem. 2021;122:1098\u20131112. doi: 10.1002/jcb.29933.", "ArticleIdList": ["10.1002/jcb.29933", "33871074"]}, {"Citation": "Yadav D.K., Kumar S., Teli M.K., Kim M.H. Ligand-based pharmacophore modeling and docking studies on vitamin D receptor inhibitors. J. Cell. Biochem. 2020;121:3570\u20133583. doi: 10.1002/jcb.29640.", "ArticleIdList": ["10.1002/jcb.29640", "31904142"]}, {"Citation": "Lagunin A., Stepanchikova A., Filimonov D., Poroikov V. PASS: Prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747\u2013748. doi: 10.1093/bioinformatics/16.8.747.", "ArticleIdList": ["10.1093/bioinformatics/16.8.747", "11099264"]}, {"Citation": "Anjum F., Ali F., Mohammad T., Shafie A., Akhtar O., Abdullaev B., Hassan M.I. Discovery of Natural Compounds as Potential Inhibitors of Human Carbonic Anhydrase II: An Integrated Virtual Screening, Docking, and Molecular Dynamics Simulation Study. OMICS J. Integr. Biol. 2021;25:513\u2013524. doi: 10.1089/omi.2021.0059.", "ArticleIdList": ["10.1089/omi.2021.0059", "34255561"]}, {"Citation": "Van Der Spoel D., Lindahl E., Hess B., Groenhof G., Mark A.E., Berendsen H.J. GROMACS: Fast, flexible, and free. J. Comput. Chem. 2005;26:1701\u20131718. doi: 10.1002/jcc.20291.", "ArticleIdList": ["10.1002/jcc.20291", "16211538"]}, {"Citation": "Sch\u00fcttelkopf A.W., Van Aalten D.M. PRODRG: A tool for high-throughput crystallography of protein\u2013ligand complexes. Acta Crystallogr. Sect. D Biol. Crystallogr. 2004;60:1355\u20131363. doi: 10.1107/S0907444904011679.", "ArticleIdList": ["10.1107/S0907444904011679", "15272157"]}, {"Citation": "Turner P. XMGRACE: Center for Coastal and Land-Margin Research. Oregon Graduate Institute of Science and Technology; Beaverton, OR, USA: 2005. Version 5.1. 19."}, {"Citation": "Yadav D.K., Kumar S., Misra S., Yadav L., Teli M., Sharma P., Chaudhary S., Kumar N., Choi E.H., Kim H.S. Molecular insights into the interaction of RONS and Thieno [3,2-c] pyran analogs with SIRT6/COX-2: A molecular dynamics study. Sci. Rep. 2018;8:4777. doi: 10.1038/s41598-018-22972-9.", "ArticleIdList": ["10.1038/s41598-018-22972-9", "PMC5859274", "29556059"]}, {"Citation": "Addie M., Ballard P., Buttar D., Crafter C., Currie G., Davies B.R., Debreczeni J., Dry H., Dudley P., Greenwood R. Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7 H-pyrrolo [2,3-d] pyrimidin-4-yl) piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases. J. Med. Chem. 2013;56:2059\u20132073. doi: 10.1021/jm301762v.", "ArticleIdList": ["10.1021/jm301762v", "23394218"]}, {"Citation": "Khan A., Mohammad T., Shamsi A., Hussain A., Alajmi M.F., Husain S.A., Iqbal M.A., Hassan M.I. Identification of plant-based hexokinase 2 inhibitors: Combined molecular docking and dynamics simulation studies. J. Biomol. Struct. Dyn. 2021;2021:1942217. doi: 10.1080/07391102.2021.1942217.", "ArticleIdList": ["10.1080/07391102.2021.1942217", "34176437"]}, {"Citation": "Amir M., Mohammad T., Prasad K., Hasan G.M., Kumar V., Dohare R., Islam A., Ahmad F., Imtaiyaz Hassan M. Virtual high-throughput screening of natural compounds in-search of potential inhibitors for protection of telomeres 1 (POT1) J. Biomol. Struct. Dyn. 2020;38:4625\u20134634. doi: 10.1080/07391102.2019.1682052.", "ArticleIdList": ["10.1080/07391102.2019.1682052", "31625455"]}, {"Citation": "Naz F., Khan F.I., Mohammad T., Khan P., Manzoor S., Hasan G.M., Lobb K.A., Luqman S., Islam A., Ahmad F. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. Int. J. Biol. Macromol. 2018;107:2580\u20132589. doi: 10.1016/j.ijbiomac.2017.10.143.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.10.143", "29079437"]}, {"Citation": "Fatima S., Mohammad T., Jairajpuri D.S., Rehman M.T., Hussain A., Samim M., Ahmad F.J., Alajmi M.F., Hassan M.I. Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain. J. Biomol. Struct. Dyn. 2020;38:3610\u20133620. doi: 10.1080/07391102.2019.1664937.", "ArticleIdList": ["10.1080/07391102.2019.1664937", "31496427"]}, {"Citation": "Lobanov M.Y., Bogatyreva N., Galzitskaya O. Radius of gyration as an indicator of protein structure compactness. Mol. Biol. 2008;42:623\u2013628. doi: 10.1134/S0026893308040195.", "ArticleIdList": ["10.1134/S0026893308040195", "18856071"]}, {"Citation": "Hubbard R.E., Haider M.K. Hydrogen Bonds in Proteins: Role and Strength. eLS; Cologne, Germany: 2010."}, {"Citation": "Dahiya R., Mohammad T., Roy S., Anwar S., Gupta P., Haque A., Khan P., Kazim S.N., Islam A., Ahmad F. Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy. Int. J. Biol. Macromol. 2019;136:1076\u20131085. doi: 10.1016/j.ijbiomac.2019.06.158.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.06.158", "31233792"]}, {"Citation": "Maisuradze G.G., Liwo A., Scheraga H.A. Principal component analysis for protein folding dynamics. J. Mol. Biol. 2009;385:312\u2013329. doi: 10.1016/j.jmb.2008.10.018.", "ArticleIdList": ["10.1016/j.jmb.2008.10.018", "PMC2652707", "18952103"]}, {"Citation": "Altis A., Otten M., Nguyen P.H., Hegger R., Stock G. Construction of the free energy landscape of biomolecules via dihedral angle principal component analysis. J. Chem. Phys. 2008;128:6B620. doi: 10.1063/1.2945165.", "ArticleIdList": ["10.1063/1.2945165", "18601386"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "16"}, {"Year": "2022", "Month": "6", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "27"}, {"Year": "2022", "Month": "7", "Day": "27", "Hour": "1", "Minute": "26"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35887580", "PMC9322152", "10.3390/jpm12071083", "jpm12071083"]}}], "PubmedBookArticle": []}